Compare Hasbro, Inc. (HAS) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hasbro, Inc. vs Johnson & Johnson — how do they compare? Hasbro, Inc. trades at $88.77 (market cap $11.53B), while Johnson & Johnson trades at $251 (market cap $598.96B). The key difference: Johnson & Johnson is far larger — about 51.9× Hasbro, Inc.'s market cap, and Hasbro, Inc. pays the higher dividend (3.44%). Which is the better fit depends on your goals.
| HAS | JNJ | |
|---|---|---|
Market Cap | $11.53B | $598.96B |
Sector | Consumer Cyclical | Health |
52-Week High | $105.88 | $267.24 |
52-Week Low | $70.95 | $164.36 |
Enterprise Value | $13.80B | $631.90B |
Dividend Yield | 3.44% | 2.15% |
Volume | — | 6,156,228 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hasbro (HAS) surged 8.87% to $88.78, driven by strong Q2 2026 earnings that beat estimates with $1.14 billion revenue (up 16% YoY) and raised full-year guidance. Technicals show bullish momentum near resistance at $85, while fundamentals reveal mixed signals: positive cash flow trends and robust Wizards segment growth contrast with negative net income margins and high debt levels. Analyst sentiment is optimistic, with a consensus price target of $104.75 and no sell ratings among 33 covered analysts.
The outlook is cautiously positive, with Magic: The Gathering fueling growth, but risks include elevated valuation multiples (P/E 25.6, EV/EBITDA 41.99) and persistent profitability challenges. Investors may see upside if execution continues, though leverage and margin pressures warrant monitoring.
Johnson & Johnson (JNJ) trades at $250.61, down 0.96% on the day, with a bullish technical signal and strong fundamental performance. Recent Q2 2026 earnings beat expectations with EPS of $2.90 versus $2.84 expected, and revenue growth of 6.6% year-over-year. The stock shows robust profitability with a net income margin of 21.48% and ROE of 26.42%, supported by consistent dividend payments including the recent $1.34 per share declared for H1-2026.
JNJ presents a favorable investment case with analyst consensus price target of $279.33 implying ~11% upside, though rising debt-to-asset ratio to 24.06% in 2025 and volatile cash flow trends pose risks. The healthcare giant's diversified portfolio and raised full-year guidance underpin long-term stability, but investors should monitor execution amid competitive and regulatory pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hasbro, Inc.
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. Ownership stakes in Discovery Family, which offers programming around Hasbro brands, and owned production capabilities from Entertainment One help bolster Hasbro's multichannel presence. The firm acquired Entertainment One in 2019, bolting on popular properties like Peppa Pig and PJ Masks, and has plans to tie up with Dungeons & Dragons Beyond in 2022, offering the firm access 10 million digital tabletop players.
Read more on HAS →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
